Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 18, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

[Current strategy for primary mediastinal germ cell tumors].

Akihiro Aoyama1, Toru Bando, Kenichi Okubo

  • 1Department of Thoracic Surgery, Kyoto University, Kyoto, Japan.

Nihon Geka Gakkai Zasshi
|December 7, 2006
PubMed
Summary

Cisplatin-based chemotherapy significantly improves survival rates for malignant mediastinal germ cell tumors (MGCTs). This treatment, combined with surgery, offers a high cure rate for these rare cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma.

Thoracic cancer·2026
Same author

Induction chemoradiotherapy to avoid pneumonectomy in centrally located non-small cell lung cancer.

General thoracic and cardiovascular surgery·2026
Same author

Pre-weekend effect in pulmonary resection for non-small cell lung cancer: a multicenter retrospective cohort study.

Surgery today·2026
Same author

Cooperative response loops enhanced by histamine signaling during tumor-neutrophil crosstalk in pleural mesothelioma.

Cell reports·2026
Same author

Histology-Based Induction Chemoradiotherapy Followed by Surgery for Stage IIIA-N2 Non-Small Cell Lung Cancer: A Prospective Observational Study.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·2026
Same author

Tumor Microenvironment Acidosis and Alkalization-Oriented Interventions in Advanced Solid Tumors: A Narrative Review and Science-Based Medicine Perspective on Long-Tail Survival.

Cancers·2026

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Genetics

Background:

  • Mediastinal germ cell tumors (MGCTs) share histological similarities with gonadal germ cell tumors but represent a distinct clinical entity.
  • Treatment strategies for MGCTs, particularly malignant types, are guided by limited evidence from retrospective studies due to the rarity of the condition.

Observation:

  • Mature teratomas are curable with surgical resection alone.
  • Malignant MGCTs, including seminomas and non-seminomas, are primarily managed with cisplatin-based chemotherapy, often in conjunction with surgery and radiation.
  • A review of 30 cases at the institution revealed improved survival outcomes with modern chemotherapy regimens.

Findings:

  • Seventeen of 18 patients with malignant MGCT survived following surgery and cisplatin-based chemotherapy.

Related Experiment Videos

Last Updated: Jul 18, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

  • In contrast, only 3 of 12 patients survived before the introduction of cisplatin.
  • Current management for non-seminomatous MGCT involves neoadjuvant cisplatin-based chemotherapy followed by surgery, potentially including high-dose chemotherapy with stem cell transplantation.

    • Implications:

    • Cisplatin-based chemotherapy has dramatically improved the prognosis for malignant MGCT.
    • The established treatment paradigm for non-seminomatous MGCT emphasizes chemotherapy prior to surgical intervention.
    • Further research and evidence generation are crucial for refining treatment decisions in rare entities like MGCT.